Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
PULMOPHARMA ApS
APS
Active
Reklamebeskyttelse
CVR 36428023
Bøgebjerg 2, 8400
Ebeltoft
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2014 · 11 years old
— employees
Overvåg
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
PULMOPHARMA ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Gross profit
-1
-80
-56
-47
-20
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-1
-80
-56
-47
-20
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-1
-80
-56
-47
-20
Net financials
-18
-13
-6
0
0
Profit before tax
-19
-93
-63
-47
-20
Tax
-0
-0
-0
-0
-0
Net profit
-19
-93
-63
-47
-20
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
80
3.987
4.953
8.896
9.326
Equity
-395
3.512
3.449
7.402
7.381
Long-term debt
0
0
0
0
0
Short-term debt
475
475
1.505
1.495
1.945
Total debt
475
475
1.505
1.495
1.945
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
-2049900.0%
This company
2020
2024
Soliditetsgrad
79.1%
This company
38.2%
Market median
+107% vs market
2020
2024
Egenkapitalforrentning
-0.3%
This company
18.4%
Market median
-102% vs market
2020
2024
Nettoresultatgrad (af bruttofortjeneste)
-2049900.0%
This company
2020
2024
Aktivomsætning (af bruttofortjeneste)
-0.00×
This company
2020
2024
Gæld/egenkapital
0.26×
This company
0.62×
Market median
+58% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on PULMOPHARMA ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
